Adapalene

This classification denotes a retinoic acid agent with the molecular formula C28H28O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1L4806J2QF, chemically known as 2-naphthalenecarboxylic acid, 6-(4-methoxy-3-tricyclo(3.3.1.1(sup 3,7))dec-1-ylphenyl)- but generally known as adapalene, which bears US NIH Compound Identifier 60164. European Medicines Agency schedules Adapalene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05261MIG. The term ADAPALENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules adapalene in its Anatomical Therapeutic Chemical (ATC) Classification. ADAPALENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule adapalene under HS 29189900 and SITC 51396. As of Q4 2014, ADAPALENE remains the US FDA Preferred Term for this commodity. Adapalene bears US NLM identifiers UMLS ID C0165631 and NCI Concept Code C28989. SMILES: O(C1C(C23CC4CC(C3)CC(C2)C4)CC(CC1)C1CC2C(CC1)CC(CC2)C(=O)O)C.